Cargando…
Population pharmacokinetic/pharmacodynamic modeling of the psychedelic experience induced by N,N‐dimethyltryptamine – Implications for dose considerations
N,N‐dimethyltryptamine (DMT) is a psychedelic compound that is believed to have potential as a therapeutic option in several psychiatric disorders. The number of clinical investigations with DMT is increasing. However, very little is known about the pharmacokinetic properties of DMT as well as any r...
Autores principales: | Eckernäs, Emma, Timmermann, Christopher, Carhart‐Harris, Robin, Röshammar, Daniel, Ashton, Michael |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9747126/ https://www.ncbi.nlm.nih.gov/pubmed/36088656 http://dx.doi.org/10.1111/cts.13410 |
Ejemplares similares
-
N,N‐dimethyltryptamine affects electroencephalography response in a concentration‐dependent manner—A pharmacokinetic/pharmacodynamic analysis
por: Eckernäs, Emma, et al.
Publicado: (2023) -
Optimized infusion rates for N,N‐dimethyltryptamine to achieve a target psychedelic intensity based on a modeling and simulation framework
por: Eckernäs, Emma, et al.
Publicado: (2023) -
Phenomenology and content of the inhaled N, N-dimethyltryptamine (N, N-DMT) experience
por: Lawrence, David Wyndham, et al.
Publicado: (2022) -
Pharmacokinetics of N,N-dimethyltryptamine in Humans
por: Good, Meghan, et al.
Publicado: (2023) -
Administration of N,N-dimethyltryptamine (DMT) in psychedelic therapeutics and research and the study of endogenous DMT
por: Barker, Steven A.
Publicado: (2022)